Tech Company Inital Public Offerings
Elevation Oncology IPO
Headquartered in New York, Elevation Oncology went public.
Transaction Overview
Company Name
Announced On
6/25/2021
Transaction Type
IPO
Amount
$100,800,000
Proceeds Purpose
Use of proceeds for the Elevation Oncology IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
888 7th Ave. 12th Floor
New York, NY 10106
USA
New York, NY 10106
USA
Phone
Website
Email Address
Overview
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Steve Elms
Chief Executive Officer
Shawn Leland
Vice President
Douglas Plessinger
Vice President
Siera Talbott
VP - Regulatory Affairs
Amy Cavers
VP - Regulatory Affairs
Sheila Magil
Browse more venture capital transactions:
Prev: 6/25/2021: Gliknik venture capital transaction
Next: 6/25/2021: Graylog venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs